Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125723931 | 12572393 | 1 | I | 20160429 | 20160713 | 20160719 | 20160719 | EXP | PHHY2016DE098868 | NOVARTIS | 0.00 | A | M | Y | 0.00000 | 20160720 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125723931 | 12572393 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | 80400 | MG | 22068 | 600 | MG | CAPSULE | QD | ||||
125723931 | 12572393 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | 80400 | MG | 22068 | 600 | MG | CAPSULE | QD | ||||
125723931 | 12572393 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
125723931 | 12572393 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
125723931 | 12572393 | 5 | C | GLIMEPIRID | GLIMEPIRIDE | 1 | Unknown | 3 MG, UNK | 0 | 3 | MG | ||||||||
125723931 | 12572393 | 6 | C | DELIX | RAMIPRIL | 1 | Unknown | 10 MG, UNK | 0 | 10 | MG | ||||||||
125723931 | 12572393 | 7 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 5 MG, UNK | 0 | 5 | MG | ||||||||
125723931 | 12572393 | 8 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 1600 MG, UNK | 0 | 1600 | MG | ||||||||
125723931 | 12572393 | 9 | C | LEVEMIR | INSULIN DETEMIR | 1 | Unknown | 50 IE, UNK | 0 | ||||||||||
125723931 | 12572393 | 10 | C | TRULICITY | DULAGLUTIDE | 1 | Unknown | 1.5 MG, QW | 0 | 1.5 | MG | /wk | |||||||
125723931 | 12572393 | 11 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | Unknown | 80 MG, UNK | 0 | 80 | MG | ||||||||
125723931 | 12572393 | 12 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | ||||||||
125723931 | 12572393 | 13 | C | MCP | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 30 MG, UNK | N | 0 | 30 | MG | |||||||
125723931 | 12572393 | 14 | C | NOVAMINOSULFON | METAMIZOLE SODIUM | 1 | Unknown | 500/UNTIL 120 GTT, UNK | 0 | 120 | GTT |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125723931 | 12572393 | 1 | Chronic myeloid leukaemia |
125723931 | 12572393 | 3 | Product used for unknown indication |
125723931 | 12572393 | 4 | Product used for unknown indication |
125723931 | 12572393 | 5 | Product used for unknown indication |
125723931 | 12572393 | 6 | Product used for unknown indication |
125723931 | 12572393 | 7 | Product used for unknown indication |
125723931 | 12572393 | 8 | Product used for unknown indication |
125723931 | 12572393 | 9 | Product used for unknown indication |
125723931 | 12572393 | 10 | Product used for unknown indication |
125723931 | 12572393 | 11 | Product used for unknown indication |
125723931 | 12572393 | 13 | Product used for unknown indication |
125723931 | 12572393 | 14 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125723931 | 12572393 | Back pain | |
125723931 | 12572393 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125723931 | 12572393 | 1 | 20151218 | 20160429 | 0 | |
125723931 | 12572393 | 2 | 20160527 | 0 | ||
125723931 | 12572393 | 11 | 20151224 | 20160317 | 0 | |
125723931 | 12572393 | 12 | 20160318 | 0 | ||
125723931 | 12572393 | 13 | 20151224 | 20160317 | 0 | |
125723931 | 12572393 | 14 | 20151224 | 0 |